These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
197 related items for PubMed ID: 1582439
1. Comparison of the effect of GIP and GLP-1 (7-36amide) on insulin release from rat pancreatic islets. Siegel EG, Schulze A, Schmidt WE, Creutzfeldt W. Eur J Clin Invest; 1992 Mar; 22(3):154-7. PubMed ID: 1582439 [Abstract] [Full Text] [Related]
2. Priming effect of glucagon-like peptide-1 (7-36) amide, glucose-dependent insulinotropic polypeptide and cholecystokinin-8 at the isolated perfused rat pancreas. Fehmann HC, Göke R, Göke B, Bächle R, Wagner B, Arnold R. Biochim Biophys Acta; 1991 Feb 19; 1091(3):356-63. PubMed ID: 1705823 [Abstract] [Full Text] [Related]
3. Comparison of GLP-1 (7-36amide) and GIP on release of somatostatin-like immunoreactivity and insulin from the isolated rat pancreas. Schmid R, Schusdziarra V, Aulehner R, Weigert N, Classen M. Z Gastroenterol; 1990 Jun 19; 28(6):280-4. PubMed ID: 2238756 [Abstract] [Full Text] [Related]
6. Insulinotropic effects of cholecystokinin, gastric inhibitory polypeptide and glucagon-like peptide-1 during perifusion of short-term cultured canine isolated islets. van der Burg MP, Guicherit OR, Frölich M, Gooszen HG. Regul Pept; 1995 Dec 07; 60(1):61-7. PubMed ID: 8747785 [Abstract] [Full Text] [Related]
7. The insulinotropic actions of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (7-37) in normal and diabetic subjects. Elahi D, McAloon-Dyke M, Fukagawa NK, Meneilly GS, Sclater AL, Minaker KL, Habener JF, Andersen DK. Regul Pept; 1994 Apr 14; 51(1):63-74. PubMed ID: 8036284 [Abstract] [Full Text] [Related]
8. Reduced insulinotropic effects of glucagonlike peptide I-(7-36)-amide and gastric inhibitory polypeptide in isolated perfused diabetic rat pancreas. Suzuki S, Kawai K, Ohashi S, Mukai H, Murayama Y, Yamashita K. Diabetes; 1990 Nov 14; 39(11):1320-5. PubMed ID: 2146178 [Abstract] [Full Text] [Related]
12. Insulinotropic actions of exendin-4 and glucagon-like peptide-1 in vivo and in vitro. Parkes DG, Pittner R, Jodka C, Smith P, Young A. Metabolism; 2001 May 14; 50(5):583-9. PubMed ID: 11319721 [Abstract] [Full Text] [Related]
13. Prior in vitro exposure to GLP-1 with or without GIP can influence the subsequent beta cell responsiveness. Delmeire D, Flamez D, Moens K, Hinke SA, Van Schravendijk C, Pipeleers D, Schuit F. Biochem Pharmacol; 2004 Jul 01; 68(1):33-9. PubMed ID: 15183115 [Abstract] [Full Text] [Related]
14. Effects of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-I-(7-36) on insulin secretion. Jia X, Brown JC, Ma P, Pederson RA, McIntosh CH. Am J Physiol; 1995 Apr 01; 268(4 Pt 1):E645-51. PubMed ID: 7733263 [Abstract] [Full Text] [Related]
15. Peptidergic regulation of maturation of the stimulus-secretion coupling in fetal islet beta cells. Sjöholm A, Sandberg E, Ostenson CG, Efendić S. Pancreas; 2000 Apr 01; 20(3):282-9. PubMed ID: 10766455 [Abstract] [Full Text] [Related]
20. The role of the free cytosolic calcium level in beta-cell signal transduction by gastric inhibitory polypeptide and glucagon-like peptide I(7-37). Lu M, Wheeler MB, Leng XH, Boyd AE. Endocrinology; 1993 Jan 01; 132(1):94-100. PubMed ID: 8380389 [Abstract] [Full Text] [Related] Page: [Next] [New Search]